PROCYON CORPORATION

PCYN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Revenue $5.0M $4.7M $4.8M $4.7M $4.3M $4.2M $4.0M $4.0M
Cost of Revenue $1.1M $1.1M $1.4M $1.3M $1.1M $1.1M $1.1M $1.3M
Gross Profit $3.9M $3.6M $3.5M $3.4M $3.2M $3.0M $2.9M $2.7M
Gross Margin 78.1% 76.2% 72.0% 71.8% 73.8% 72.8% 73.0% 68.5%
Operating Expenses
Research & Development $30.1K $30.6K $30.0K $30.9K $23.1K $33.1K $41.7K $31.3K
SG&A Expense $2.0M $1.8M $1.7M $1.3M $1.3M $1.4M $1.3M $1.2M
Operating Income $-231.7K $-97.4K $-237.2K $226.7K $153.0K $97.1K $127.1K $30.0K
Operating Margin -4.6% -2.1% -4.9% 4.8% 3.5% 2.3% 3.2% 0.7%
Interest Expense $0 $0 $0 $2.2K $0 $0 $0 $2.8K
Pretax Income $-171.3K $-65.4K $-235.4K $733.8K $160.1K $99.3K $127.6K $29.0K
Income Tax Expense $169.9K $-15.1K $-25.6K $39.4K $48.4K $72.1K $383.4K $16.6K
Net Income $-341.1K $-50.2K $-209.8K $694.3K $111.7K $27.2K $-255.7K $12.4K
Net Margin -6.8% -1.1% -4.3% 14.7% 2.6% 0.6% -6.4% 0.3%
EPS (Basic) $-0.04 $-0.01 $-0.03 $0.08 $0.01 $0.00 $-0.03 $0.00
EPS (Diluted) $-0.04 $-0.01 $-0.03 $0.08 $0.01 $0.00 $-0.03 $0.00
Shares Outstanding (Basic) 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M
Shares Outstanding (Diluted) 8.1M 8.1M 8.1M 8.3M 8.3M 8.3M 8.1M 8.3M
Dividends Per Share
← Newer Page 1 of 2 Older →